PACE-CME

A polypill for secondary prevention in post-MI patients

A polypill for secondary prevention in postMI patients
RestartResume
3' education - Aug. 26, 2022 - Valentin Fuster, MD, PhD
  • Overview

    ESC 2022 Is a polypill better than taking separate pills in patients following MI? Valentin Fuster shares the findings of the SECURE trial.

  • Educational information

    This video was recorded during the ESC Congress 2022 in Barcelona, Spain.

  • Faculty

    Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, New York, NY, USA. He is the General Director of the National Center for Cardiovascular investigation or CNIC in Madrid, Spain.

  • Disclosures

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Read our summary of the SECURE trial

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free